Using data on over 200,000 children, Cochrane researchers reach a positive conclusion for zinc supplements.
The importance of zinc cannot be stressed enough. Zinc is an essential trace element. But in countries where zinc deficiency is common, and food is hard to come by, zinc supplements may have some good use.
Reporting their results in The Cochrane Library, researchers led by Evan Mayo-Wilson performed about as big of a zinc meta-analysis as you can get. Using data from 80 qualified random controlled trials on 205,401 children, they compared health outcomes between children supplementing with and without zinc.
Zinc supplements seemed to influence a reduced risk of diarrhea, an outcome also reported in a previous Cochrane review on fewer trials. The effects of this one supplement based on the new data, however, extended to increases in child height and, not surprisingly, a “medium to large effect on zinc status.” Even though this nutrient has been associated with reductions in lower respiratory tract infections and malaria incidence in previous trials, this round-up of data did not support these previous findings.
Zinc deficiency is a critical issue in many developing countries, and estimates suggest that one of every six people on Earth is deficient in zinc.
Photo by ©iStockphoto.com/victorhe2002
Robby Gardner
Associate Editor
Nutritional Outlook magazine
robby.gardner@ubm.com
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.